Medicover AB (publ) (MCVEF)
MCVEF Stock Price Chart
Explore Medicover AB (publ) interactive price chart. Choose custom timeframes to analyze MCVEF price movements and trends.
MCVEF Company Profile
Discover essential business fundamentals and corporate details for Medicover AB (publ) (MCVEF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
28 Aug 2019
Employees
47.00K
Website
https://www.medicover.comCEO
John Paul Stubbington
Description
Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
MCVEF Financial Timeline
Browse a chronological timeline of Medicover AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 10 Feb 2026
Upcoming earnings on 5 Nov 2025
Earnings released on 24 Jul 2025
EPS came in at $0.15 surpassing the estimated $0.14 by +5.97%, while revenue for the quarter reached $702.58M , missing expectations by -1.21%.
Earnings released on 29 Apr 2025
EPS came in at $0.15 surpassing the estimated $0.10 by +51.54%, while revenue for the quarter reached $633.74M , missing expectations by -3.81%.
Earnings released on 12 Feb 2025
EPS came in at $0.06 surpassing the estimated $0.04 by +39.75%, while revenue for the quarter reached $575.53M , beating expectations by +1.18%.
Dividend declared on 12 Feb 2025
A dividend of $0.17 per share was announced, adjusted to $0.18. The dividend was paid on 9 May 2025.
Earnings released on 30 Oct 2024
EPS came in at -$0.03 falling short of the estimated $0.08 by -141.24%, while revenue for the quarter reached $578.85M , beating expectations by +1.00%.
Earnings released on 25 Jul 2024
EPS came in at $0.05 falling short of the estimated $0.06 by -29.80%, while revenue for the quarter reached $547.73M , beating expectations by +1.20%.
Earnings released on 26 Apr 2024
EPS came in at $0.04 surpassing the estimated $0.03 by +36.82%, while revenue for the quarter reached $535.85M , beating expectations by +0.03%.
Earnings released on 9 Feb 2024
EPS came in at $0.09 surpassing the estimated $0.03 by +175.89%, while revenue for the quarter reached $521.14M , beating expectations by +1.12%.
Dividend declared on 9 Feb 2024
A dividend of $0.13 per share was announced, adjusted to $0.14. The dividend was paid on 8 May 2024.
Earnings released on 30 Sept 2023
EPS came in at -$0.01 falling short of the estimated $0.05 by -113.34%, while revenue for the quarter reached $464.66M , beating expectations by +2.67%.
Earnings released on 30 Jun 2023
EPS came in at $0.04 falling short of the estimated $0.19 by -79.12%, while revenue for the quarter reached $463.31M , beating expectations by +0.50%.
Earnings released on 31 Mar 2023
EPS came in at $0.01 falling short of the estimated $0.19 by -94.26%, while revenue for the quarter reached $455.87M , beating expectations by +3.43%.
Earnings released on 17 Feb 2023
EPS came in at $0.01 falling short of the estimated $0.15 by -90.83%, while revenue for the quarter reached $428.39M , beating expectations by +2.81%.
Dividend declared on 17 Feb 2023
A dividend of $0.13 per share was announced, adjusted to $0.14. The dividend was paid on 9 May 2023.
Earnings released on 3 Nov 2022
EPS came in at -$0.02 falling short of the estimated $0.01 by -340.82%, while revenue for the quarter reached $359.96M , beating expectations by +7.49%.
Earnings released on 22 Jul 2022
EPS came in at $0.01 falling short of the estimated $0.02 by -49.76%, while revenue for the quarter reached $378.87M , beating expectations by +1.33%.
Earnings released on 27 Apr 2022
EPS came in at $0.09 , while revenue for the quarter reached $422.21M , beating expectations by +4.38%.
Earnings released on 11 Feb 2022
EPS came in at $0.24 surpassing the estimated -$0.06 by +520.38%, while revenue for the quarter reached $426.62M , beating expectations by +6.47%.
Dividend declared on 11 Feb 2022
A dividend of $0.13 per share was announced, adjusted to $0.14. The dividend was paid on 6 May 2022.
Earnings released on 3 Nov 2021
EPS came in at $0.16 falling short of the estimated $0.20 by -17.63%, while revenue for the quarter reached $388.83M .
Earnings released on 23 Jul 2021
EPS came in at $0.24 , while revenue for the quarter reached $413.95M .
Earnings released on 29 Apr 2021
EPS came in at $0.20 , while revenue for the quarter reached $373.09M .
Earnings released on 12 Feb 2021
EPS came in at $0.15 , while revenue for the quarter reached $365.09M .
Dividend declared on 12 Feb 2021
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 10 May 2021.
Earnings released on 6 Nov 2020
EPS came in at $0.13 , while revenue for the quarter reached $308.20M .
MCVEF Stock Performance
Access detailed MCVEF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.